Optimal timing of SARS-CoV-2 vaccination prior to cardiovascular surgery under cardiopulmonary bypass
CONCLUSIONS: Although 40% of the RBD-IgG titers reduce 1 day after CPB surgery, the patients who received the SARS-COV-2 vaccination within an 81-day window prior to the surgery maintained a desirable RBD-IgG level, even up to 1 month after surgery. It may be important to schedule the surgery no later than 81 days after the vaccination.PMID:38415725 | DOI:10.1177/03913988241234475 (Source: The International Journal of Artificial Organs)
Source: The International Journal of Artificial Organs - February 28, 2024 Category: Transplant Surgery Authors: Ryosuke Hayashi Yoshiyuki Takami Hidetsugu Fujigaki Kentaro Amano Kiyotoshi Akita Koji Yamana Atsuo Maekawa Kuniaki Saito Yasushi Takagi Source Type: research
Respiratory Syncytial Virus Vaccination in Older Adults: Considerations for Use and Shared Clinical Decision-Making
CONCLUSION: The introduction of RSVpreF3 and RSVpreF vaccines represents a significant advancement in the management of RSV in older adults. This article underscores the importance of shared clinical decision-making in vaccine administration and the effective coordination of an interprofessional team for coadministration with other vaccines. [Journal of Gerontological Nursing, 50(3), 7-12.].PMID:38417072 | DOI:10.3928/00989134-20240207-02 (Source: Journal of Gerontological Nursing)
Source: Journal of Gerontological Nursing - February 28, 2024 Category: Nursing Authors: Morgan A Gerber Michael K Burke Michael R Brodeur Source Type: research
Optimal timing of SARS-CoV-2 vaccination prior to cardiovascular surgery under cardiopulmonary bypass
CONCLUSIONS: Although 40% of the RBD-IgG titers reduce 1 day after CPB surgery, the patients who received the SARS-COV-2 vaccination within an 81-day window prior to the surgery maintained a desirable RBD-IgG level, even up to 1 month after surgery. It may be important to schedule the surgery no later than 81 days after the vaccination.PMID:38415725 | DOI:10.1177/03913988241234475 (Source: The International Journal of Artificial Organs)
Source: The International Journal of Artificial Organs - February 28, 2024 Category: Transplant Surgery Authors: Ryosuke Hayashi Yoshiyuki Takami Hidetsugu Fujigaki Kentaro Amano Kiyotoshi Akita Koji Yamana Atsuo Maekawa Kuniaki Saito Yasushi Takagi Source Type: research
Tracking the immune response profiles elicited by the BNT162b2 vaccine in COVID-19 unexperienced and experienced individuals
Clin Immunol. 2024 Feb 26:110164. doi: 10.1016/j.clim.2024.110164. Online ahead of print.ABSTRACTMultiple vaccines have been approved to control COVID-19 pandemic, with Pfizer/BioNTech (BNT162b2) being widely used. We conducted a longitudinal analysis of the immune response elicited after three doses of the BNT162b2 vaccine in individuals who have previously experienced SARS-CoV-2 infection and in unexperienced ones. We conducted immunological analyses and single-cell transcriptomics of circulating T and B lymphocytes, combined to CITE-seq or LIBRA-seq, and VDJ-seq. We found that antibody levels against SARS-CoV-2 Spike, N...
Source: Clinical Immunology - February 28, 2024 Category: Allergy & Immunology Authors: Eugenia Galeota Valeria Bevilacqua Andrea Gobbini Paola Gruarin Mauro Bombaci Elisa Pesce Andrea Favalli Andrea Lombardi Francesca Vincenti Jessica Ongaro Tanya Fabbris Serena Curti Martina Martinovic Mirco Toccafondi Mariangela Lorenzo Angelica Critelli Source Type: research
Respiratory Syncytial Virus Vaccination in Older Adults: Considerations for Use and Shared Clinical Decision-Making
CONCLUSION: The introduction of RSVpreF3 and RSVpreF vaccines represents a significant advancement in the management of RSV in older adults. This article underscores the importance of shared clinical decision-making in vaccine administration and the effective coordination of an interprofessional team for coadministration with other vaccines. [Journal of Gerontological Nursing, 50(3), 7-12.].PMID:38417072 | DOI:10.3928/00989134-20240207-02 (Source: Journal of Gerontological Nursing)
Source: Journal of Gerontological Nursing - February 28, 2024 Category: Nursing Authors: Morgan A Gerber Michael K Burke Michael R Brodeur Source Type: research
Respiratory Syncytial Virus Vaccination in Older Adults: Considerations for Use and Shared Clinical Decision-Making
CONCLUSION: The introduction of RSVpreF3 and RSVpreF vaccines represents a significant advancement in the management of RSV in older adults. This article underscores the importance of shared clinical decision-making in vaccine administration and the effective coordination of an interprofessional team for coadministration with other vaccines. [Journal of Gerontological Nursing, 50(3), 7-12.].PMID:38417072 | DOI:10.3928/00989134-20240207-02 (Source: Journal of Gerontological Nursing)
Source: Journal of Gerontological Nursing - February 28, 2024 Category: Nursing Authors: Morgan A Gerber Michael K Burke Michael R Brodeur Source Type: research
